What we do

  • We apply our world-leading expertise in therapeutic immunology to our clients' programmes. 
  • We tailor our work to provide solutions to even the most challenging  programmes in immunology, inflammation and infection.

KWS BioTest has recently been acquired by Charles River Laboratories, learn more here.

At KWS BioTest, the latest methods and technologies are in the hands of scientific experts - from world-leading expertise of our CSO, Professor Neil Williams, to the extensive experience of our highly-trained staff. We generate high-quality data and assist in its interpretation through every step of your preclinical or clinical research programme. Combined, our staff and services provide you with improved decision-making.

We offer validated in vitro and in vivo models in:

  • Immuno-oncology
  • Autoimmune disease
  • Inflammation and allergy
  • Anti-microbials, anti-virals and vaccinology

We constantly update our services through in-house development of new, innovative models and assays with improved translational value. We work with clients in some of the fastest moving therapeutic areas in pharma and our internal development programmes are designed to anticipate the evolving demands of our clients.

KWS BioTest provides services spanning preclinical and clinical phases. We have an expert team of cell biologists to support early research.

KWS BioTest supports later stage drug development programmes.